F. Markus Leweke

University of Sydney — Australia

Medicine · Health Sciences

60h-index13.2kcitations235works4.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cannabis and Cannabinoid Research(69), Tryptophan and brain disorders(45), Schizophrenia research and treatment(42), Neurotransmitter Receptor Influence on Behavior(27), Neuroscience and Neuropharmacology Research(25)

Publications234 total

Relapse in Schizophrenia: A Systematic Review of Criteria for Clinical Studies and International Consensus Guidelines to Improve Them
American Journal of Psychiatry·2025· 3 cited
Cerebrospinal fluid metabolomics in autistic regression reveals dysregulation of sphingolipids and decreased β-hydroxybutyrate
EBioMedicine·2025· 8 citedOpen Access
Novel youth mental health services in Australia: What differences are being reported about the clinical needs of those who attend and the outcomes achieved?
Australian & New Zealand Journal of Psychiatry·2025· 12 citedOpen Access
Conclusion
Elsevier eBooks·2024
Contributors
Elsevier eBooks·2024Open Access
Erratum zu: Nachruf auf Prof. Dr. Dr. Hinderk Meiners Emrich (1943–2018)
Der Nervenarzt·2024Open Access
Alterations to sphingolipid metabolism from antipsychotic administration in healthy volunteers are restored following the use of cannabidiol
Psychiatry Research·2024· 3 citedOpen Access
ReTimeML: a retention time predictor that supports the LC–MS/MS analysis of sphingolipids
Scientific Reports·2024· 3 citedOpen Access
Cannabidiol and its Potential Evidence-Based Psychiatric Benefits – A Critical Review
Pharmacopsychiatry·2024· 18 citedOpen Access
Dose-dependent effects of oral cannabidiol and delta-9-tetrahydrocannabinol on serum anandamide and related N-acylethanolamines in healthy volunteers
BMJ Mental Health·2024· 2 citedOpen Access
Neuroimmune-mediated neuropsychiatric syndromes: perspectives for standardised diagnostics and personalised care
Research Directions Depression·2024· 1 citedOpen Access
Is immune activation simply a non-specific marker of depression severity or chronicity or does it indicate an underlying pathophysiological path to depressive or other mood disorders?
Research Directions Depression·2023· 3 citedOpen Access
Plasma endocannabinoids in cocaine dependence and their relation to cerebral metabotropic glutamate receptor 5 density
Translational Psychiatry·2023· 12 citedOpen Access
Repurposing of recreational drugs: will these new ‘medicines’ (e.g., psychedelics, psilocybin, cannabinoids, LSD, MDMA, ketamine) deliver short- or longer-term benefits for those with depressive or other mood disorders?
Research Directions Depression·2023· 1 citedOpen Access
EMPOWERED trial: protocol for a randomised control trial of digitally supported, highly personalised and measurement-based care to improve functional outcomes in young people with mood disorders
BMJ Open·2023· 9 citedOpen Access
Complement proteins are elevated in blood serum but not CSF in clinical high-risk and antipsychotic-naïve first-episode psychosis
Brain Behavior and Immunity·2023· 16 citedOpen Access
Cannabidiol as a Potential Antipsychotic
Cambridge University Press eBooks·2023· 1 cited
Plasma endocannabinoids in cocaine dependence and their interaction with cocaine craving and metabotropic glutamate receptor 5 density in the human brain
2023· 2 citedOpen Access
Clozapine Optimization: A Delphi Consensus Guideline From the Treatment Response and Resistance in Psychosis Working Group
Schizophrenia Bulletin·2023· 35 citedOpen Access
Cannabidiol enhances cerebral glucose utilization and ameliorates psychopathology and cognition: A case report in a clinically high-risk mental state
Frontiers in Psychiatry·2023· 5 citedOpen Access
page 1 of 12Next →

Frequent Co-authors

Dagmar Koethe(25), Sabine Bahn(11), C.W. Gerth(9), Robert H. Yolken(9), Paul C. Guest(9), Emanuel Schwarz(8), Joachim Klosterkötter(7), Daniela Schreiber(7), Sabine Bahn(7), Hassan Rahmoune(7), Johann Steiner(7), H. M. Emrich(6), Laura Kranaster(6), Matthias Rothermundt(6), Yishai Levin(6), Daniele Piomelli(5), Udo Schneider(5), Cathrin Rohleder(5), Nico J.M. van Beveren(4), Martin Hellmich(4)